- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Chest radiography CAD system highlights hidden areas
Riverain Medical has added features to its lung cancer computer-aided detection system for chest radiography that are intended to make the program more accurate. The enhancements reduce false positive rates when evaluating solitary lung nodules in regions of interest located in the hilar area and near the ribs.
Riverain Medical has added features to its lung cancer computer-aided detection system for chest radiography that are intended to make the program more accurate. The enhancements reduce false positive rates when evaluating solitary lung nodules in regions of interest located in the hilar area and near the ribs.
At the RSNA meeting, the company introduced lateral CAD and rib-over-rib upgrades in a new version of its RapidScreen early cancer detection system, pending FDA premarket approval.
Lateral CAD is designed to focus on the 5% of cases of lung cancer that are missed because they cannot easily be seen on lateral views, according to Kevin E. McBride, vice president of marketing. Both lateral CAD and the rib-over-rib feature aim to reduce the rate of redundant regions of interest that are similar to and may be confused with solitary pulmonary nodules.
The company is also testing a dual energy subtraction CAD system to find suspicious lesions in difficult-to-see areas on chest scans. This capability is a work in progress targeted at the 400 to 500 digital radiography chest systems that are estimated to be on the market, McBride said.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
2 Commerce Drive
Cranbury, NJ 08512
All rights reserved.